Syndrome of inappropriate antidiuretic hormone secretion associated with prolonged keterolac use

Sian Yik Lim, Ragesh Panikkath, Sharma Prabhakar, Sian Yik Lim, Ragesh Panikkath, Sharma Prabhakar

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used analgesics. Although rare, clinicians need to keep in mind that their use may precipitate hyponatremia and syndrome of inappropriate antidiuretic hormone (SIADH), especially in high-risk patients with multiple comorbidities. In the kidneys, prostaglandins attenuate the water retention effect of antidiuretic hormone. NSAIDs cause a decrease in prostaglandins in the kidney and therefore the effect of ADH is potentiated. We report a case of SIADH that was associated with keterolac in a 65-year-old male. SIADH has not previously been reported with keterolac, a strong NSAID with comparable analgesic effect as morphine and meperidine. Keterolac may have unique properties different from other NSAIDS which may predispose to the development of hyponatremia. In our case, prolonged use of keterolac may have contributed to the development of SIADH and caution is needed when keterolac is used for prolonged duration. A review of the literature regarding development of SIADH and hyponatremia in the setting of NSAIDs is also presented.

Keywords: keterolac; nonsteroidal anti-inflammatory drugs; prostaglandins; syndrome of inappropriate antidiuretic hormone secretion.

Figures

Figure 1.. Sodium levels during hospitalization, D…
Figure 1.. Sodium levels during hospitalization, D = hospital admission day, IV = intravenously. X-day keterolac was stopped.

References

    1. Zhou Y Boudreau DM Freedman AN Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population. Pharmacoepidemiol Drug Saf. 2013; [Epub ahead of print].
    1. Dugowson CE Gnanashanmugam P Nonsteroidal anti-inflammatory drugs. Phys Med Rehabil Clin N Am. 2006; 17: 347–354.
    1. Rault RM Case report: hyponatremia associated with nonsteroidal antiinflammatory drugs. Am J Med Sci. 1993; 305: 318–320.
    1. Ellison DH Berl T Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007; 356: 2064–2072.
    1. Trabert W Caspari D Bernhard P Biro G Inappropriate vasopressin secretion in severe alcohol withdrawal. Acta Psychiatr Scand. 1992; 85: 376–379.
    1. Berl T Raz A Wald H Horowitz J Czaczkes W Prostaglandin synthesis inhibition and the action of vasopressin: studies in man and rat. Am J Physiol. 1977; 232: F529–F537.
    1. Liamis G Milionis H Elisaf M A review of drug-induced hyponatremia. Am J Kidney Dis. 2008; 52: 144–153.
    1. Rose BD Post TW Clinical physiology of acidbase and electrolyte disorders. New York: McGraw-Hill, Medical Pub. Division; 2001.
    1. Hammerman C Zaia W Wu HH Severe hyponatremia with indomethacin--a more serious toxicity than previously realized? Dev Pharmacol Ther. 1985; 8: 260–267.
    1. Page AJ Reid SA Speedy DB Mulligan GP Thompson J Exercise-associated hyponatremia, renal function, and nonsteroidal antiinflammatory drug use in an ultraendurance mountain run. Clin J Sport Med. 2007; 17: 43–48.
    1. Almond CS Shin AY Fortescue EB Mannix RC Wypij D Binstadt BA Duncan CN Olson DP Salerno AE Newburger JW Greenes DS Hyponatremia among runners in the Boston Marathon. N Engl J Med. 2005; 352: 1550–1556.
    1. Webberley MJ Murray JA Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin. Postgrad Med J. 1989; 65: 950–952.
    1. Petersson I Nilsson G Hansson BG Hedner T Water intoxication associated with non-steroidal anti-inflammatory drug therapy. Acta Med Scand. 1987; 221: 221–223.
    1. Reinhart DI Minimising the adverse effects of ketorolac. Drug Saf. 2000; 22: 487–497.
    1. Strom BL Berlin JA Kinman JL Spitz PW Hennessy S Feldman H Kimmel S Carson JL Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study. JAMA. 1996; 275: 376–382.
    1. Goodenough GK Lutz LJ Hyponatremic hypervolemia caused by a drug--drug interaction mistaken for syndrome of inappropriate ADH. J Am Geriatr Soc. 1988; 36: 285–286.
    1. Bhargava R Lewandowski BJ Water intoxication: a complication of pelvic US in a patient with syndrome of inappropriate antidiuretic hormone secretion. Radiology. 1991; 180: 723–724.
    1. Chamontin B Fille A Salva P Salvador M [Does selective inhibition of prostaglandins exist? Apropos of hyponatremia with sulindac]. Presse Med. 1988; 17: 2140–2141.
    1. Garella S Matarese RA Renal effects of prostaglandins and clinical adverse effects of nonsteroidal anti-inflammatory agents. Medicine (Baltimore). 1984; 63: 165–181.
    1. Brooks PM Day RO Nonsteroidal antiinflammatory drugs – differences and similarities. N Engl J Med. 1991; 324: 1716–1725.
    1. Domer F Characterization of the analgesic activity of ketorolac in mice. Eur J Pharmacol. 1990; 177: 127–135.
    1. Maves TJ Pechman PS Meller ST Gebhart GF Ketorolac potentiates morphine antinociception during visceral nociception in the rat. Anesthesiology. 1994; 80: 1094–1101.
    1. Ishikawa S Schrier RW Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat. J Clin Invest. 1982; 69: 666–672.
    1. Michel C Montastruc JL Valdiguié P Montastruc P Effects of morphine on urine flow in rats. Involvement of vasopressin. J Pharmacol. 1986; 17: 316–322.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren